Las Vegas NV / March 13, 2015 / Verde Science, Inc., (VRCI-OTCQB) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant developments in the Medical Marijuana R&D arena.
Verde Science has firmly established its Research and Development platform with research scientists, project directors, and research institutions based in India, Canada and the U.S.; has identified several initial promising R&D projects; and completed its consolidated R&D and business plan. “Achieving these critical steps clears the path for Verde to embark on the development of specific pharmaceutical formulations based on the marijuana plant, and enhances our ability to compete effectively in the burgeoning Medical Marijuana field,” according to Harp Sangha, Verde Science CEO.
“This is an especially timely development, as a landmark bi-partison Medical Marijuana bill called the Compassionate Access, Research Expansion and Respect States (CARERS) Act was introduced in the U.S. Senate on March 10th. The bill would remove federal penalties and restrictions for producing, distributing and possessing marijuana for medical purposes. More important for Verde Science is that the bill would eliminate current barriers to research and development and recognize the acceptable medical use of marijuana,” according to Louis Silver Verde Science Director of Investor Relations. Among the bill’s sponsors are Senators Rand Paul, Republican of Kentucky and Cory Booker, Democrat of New Jersey.
Also, on Sunday, March 15th, 2015 at 8:30 pm EST Paul Pelosi Jr. who is on VRCI’s Advisory Board, and Louis Silver Managing Director of Investor Relations, will be appearing on the popular internet radio show, Pot Stock radio, at http://potstockradio.com/pot-stock-radio-verde-science-force-fuels-wolf-weed-st-alan-brochstein/.
About Verde Science, Inc. (VRCI-OTCQB)
Verde Science, Inc. (www.VerdeScienceInc.com) is a public company trading under the symbol (VRCI-OTCQB). The Company is focused on Medical Marijuana Research and Development, and providing advisory services, quality assurance, and aeroponic growing systems in the burgeoning Medical Marijuana industry to established, licensed growers throughout Canada.
For further information please contact:
Harp Sangha, Chairman/CEO
Safe Harbor Statements
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates,” “intends” or “believes,” or that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur,” or “be achieved.” Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.